---
figid: PMC3684083__nihms459788f4
figtitle: 'EGFR/TGFA and TGFB/CTGF Signaling in Neuroendocrine Neoplasia: Theoretical
  Therapeutic Targets'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- clinical samples
pmcid: PMC3684083
filename: nihms459788f4.jpg
figlink: /pmc/articles/PMC3684083/figure/F4/
number: F4
caption: The signaling pathways activated either directly or due to cross-activation
  is MAPK and AKT/mTOR signaling. All ligands signal via these pathways to positively
  regulate proliferation and metastasis. Separately, an event that only occurs in
  a subset of GEP-NENs (Small-intestine NENs), TGFβ and CTGF activate fibrogenic pathways
  resulting in local (peritoneal) or distant (cardiac) disease. The common activation
  of RAS/RAF signaling suggests that therapeutic agents that target elements of this
  pathway may be potentially effective in NENs.
papertitle: 'EGFR/TGFα and TGFβ/CTGF Signaling in Neuroendocrine Neoplasia: Theoretical
  Therapeutic Targets.'
reftext: M. Kidd, et al. Neuroendocrinology. ;97(1):35-44.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9347681
figid_alias: PMC3684083__F4
figtype: Figure
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
redirect_from: /figures/PMC3684083__F4
ndex: 0e635963-deff-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3684083__nihms459788f4.html
  '@type': Dataset
  description: The signaling pathways activated either directly or due to cross-activation
    is MAPK and AKT/mTOR signaling. All ligands signal via these pathways to positively
    regulate proliferation and metastasis. Separately, an event that only occurs in
    a subset of GEP-NENs (Small-intestine NENs), TGFβ and CTGF activate fibrogenic
    pathways resulting in local (peritoneal) or distant (cardiac) disease. The common
    activation of RAS/RAF signaling suggests that therapeutic agents that target elements
    of this pathway may be potentially effective in NENs.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - TGFA
  - CCN2
  - TGFB1
  - TGFB2
  - TGFB3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - MTOR
  - AKT1
  - AKT2
  - AKT3
  - Egf
  - Tgfa
  - Ccn2
  - Tgfb1
  - Mtor
  - Akt1
  - Ltbp1
---
